about
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Al...
Read More
2.57
0.00
(0.00%)
470.6K
XNAS Volume
XNAS 06 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Alector Inc is on 08 May 2026 for the purpose of Alector Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..